Avenue Therapeutics Inc.

1.01
-0.09 (-8.18%)
At close: Mar 03, 2025, 3:55 PM
0.99
-1.86%
After-hours: Mar 03, 2025, 04:44 PM EST

Avenue Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Cash & Equivalents 1.78M 6.71M 3.76M 3.13M 8.74M 2.67M 11.78M 197K 14K
Short-Term Investments n/a n/a n/a n/a n/a n/a 10M n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a n/a n/a n/a 1.7M n/a n/a n/a
Receivables n/a n/a 90K n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 67K 137K 107K 113K 170K 1.85M 388K n/a n/a
Total Current Assets 1.85M 6.84M 3.96M 3.25M 8.91M 4.53M 22.17M 197K 14K
Property-Plant & Equipment n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets n/a n/a n/a n/a n/a 1.7M n/a n/a n/a
Total Assets 1.85M 6.84M 3.96M 3.25M 8.91M 4.53M 22.17M 197K 14K
Account Payables 401K 150K 362K 172K 354K 3.09M 1.54M 334K 491K
Deferred Revenue n/a n/a n/a n/a n/a n/a n/a 1.75M 676K
Short-Term Debt n/a n/a n/a n/a n/a n/a n/a 3.85M 1.17M
Other Current Liabilities 795K 3.43M 147K 714K 1.76M 2.07M 1.25M 2.24M 790K
Total Current Liabilities 1.2M 3.58M 509K 886K 2.12M 5.16M 2.79M 6.42M 2.45M
Long-Term Debt n/a n/a n/a n/a n/a n/a n/a 2.03M 2.7M
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a 949.00 n/a n/a n/a 3.58M n/a 2.03M 2.7M
Total Liabilities 1.2M 3.58M 509K 886K 2.12M 5.16M 2.79M 8.45M 5.15M
Total Debt n/a n/a n/a n/a n/a n/a n/a 5.87M 3.87M
Common Stock 3K n/a 2K 2K 2K 1K 1K 1K 1K
Retained Earnings -90.93M -80.55M -77M -73.27M -68.12M -42.21M -20.66M -8.4M -5.23M
Comprehensive Income -0.00 n/a -0.00 n/a n/a 0.00 1.1M 49K 40K
Shareholders Equity 1.58M 3.9M 3.45M 2.36M 6.8M -631K 19.38M -8.25M -5.13M
Total Investments n/a n/a n/a n/a n/a n/a 10M n/a n/a